期刊文献+

Current surgical management of pancreatic endocrine tumor liver metastases 被引量:5

Current surgical management of pancreatic endocrine tumor liver metastases
下载PDF
导出
摘要 BACKGROUND: The management of metastatic disease in pancreatic endocrine tumors (PETs) demands a multidisciplinary approach and the cooperation of several medical specialties. The role of surgery is critical, even when a radical excision cannot always be achieved. DATA SOURCES: A PubMed search of relevant articles published up to February 2011 was performed to identify current information about PET liver metastases regarding diagnosis and management, with an emphasis on surgery. RESULTS: The early diagnosis of metastases and their accurate localization, most commonly in the liver, is very important. Surgical options include radical excision, and palliative excision to relieve symptoms in case of failure of medical treatment. The goal of the radical excision is to remove the primary tumor bulk and all liver metastases at the same time, but unfortunately it is not feasible in most cases. Palliative excisions include aggressive tumor debulking surgeries in well-differentiated carcinomas, trying to remove at least 90% of the tumor mass, combined with other additional destructive techniques such as hepatic artery embolization or chemoembolization to treat metastases or chemoembolization to relieve symptoms in cases of rapidly growing tumors. The combination of chemoembolization and systemic chemotherapy results in better response and survival rates. Other local destructive techniques include ethanol injection, cryotherapy and radiofrequency ablation. CONCLUSION: It seems that the current management of PETs can achieve important improvements, even in advanced cases. BACKGROUND: The management of metastatic disease in pancreatic endocrine tumors (PETs) demands a multidisciplinary approach and the cooperation of several medical specialties. The role of surgery is critical, even when a radical excision cannot always be achieved. DATA SOURCES: A PubMed search of relevant articles published up to February 2011 was performed to identify current information about PET liver metastases regarding diagnosis and management, with an emphasis on surgery. RESULTS: The early diagnosis of metastases and their accurate localization, most commonly in the liver, is very important. Surgical options include radical excision, and palliative excision to relieve symptoms in case of failure of medical treatment. The goal of the radical excision is to remove the primary tumor bulk and all liver metastases at the same time, but unfortunately it is not feasible in most cases. Palliative excisions include aggressive tumor debulking surgeries in well-differentiated carcinomas, trying to remove at least 90% of the tumor mass, combined with other additional destructive techniques such as hepatic artery embolization or chemoembolization to treat metastases or chemoembolization to relieve symptoms in cases of rapidly growing tumors. The combination of chemoembolization and systemic chemotherapy results in better response and survival rates. Other local destructive techniques include ethanol injection, cryotherapy and radiofrequency ablation. CONCLUSION: It seems that the current management of PETs can achieve important improvements, even in advanced cases.
出处 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS 2011年第3期243-247,共5页 国际肝胆胰疾病杂志(英文版)
关键词 pancreatic endocrine tumors pancreas islet cell neoplasms neuroendocrine tumors liver metastases surgical management debulking surgery pancreatic endocrine tumors pancreas islet cell neoplasms neuroendocrine tumors liver metastases surgical management debulking surgery
  • 相关文献

参考文献47

  • 1Clinical experience in diagnosis and treatment of glucagonoma syndrome[J].Hepatobiliary & Pancreatic Diseases International,2004,3(3):473-475. 被引量:3
  • 2Laureano Fernández-Cruz,Laia Blanco,Rebeca Cosa,Héctor Rendón.Is Laparoscopic Resection Adequate in Patients with Neuroendocrine Pancreatic Tumors?[J]. World Journal of Surgery . 2008 (5)
  • 3Amir A. Ghaferi,Karen A. Chojnacki,William D. Long,John L. Cameron,Charles J. Yeo.Pancreatic VIPomas: Subject Review and One Institutional Experience[J]. Journal of Gastrointestinal Surgery . 2008 (2)
  • 4Jun Chul Chung MD,Dong Wook Choi MD,Sung Ho Jo MD,Jin Seok Heo MD,Seong Ho Choi MD, PhD,Yong Il Kim MD.Malignant Nonfunctioning Endocrine Tumors of the Pancreas: Predictive Factors for Survival after Surgical Treatment[J]. World Journal of Surgery . 2007 (3)
  • 5B. Wiedenmann,R.T. Jensen,M. Mignon,C.I. Modlin,B. Skogseid,G. Doherty,K. ?berg.Preoperative Diagnosis and Surgical Management of Neuroendocrine Gastroenteropancreatic Tumors: General Recommendations by a Consensus Workshop*[J]. World Journal of Surgery . 1998 (3)
  • 6Sakurai A,Katai M,Yamashita K,Mori J,Fukushima Y,Hashizume K.Long-term follow-up of patients with multiple endocrine neoplasia type 1. Endocrine Journal . 2007
  • 7Oberg K,Castellano D.Current knowledge on diagnosis and staging of neuroendocrine tumors. Cancer and Metastasis Reviews . 2011
  • 8Oberg K.Pancreatic endocrine tumorsSeminars in Oncology,2010.
  • 9Zerbi A,Falconi M,Rindi G,Delle Fave G,Tomassetti P,Pasquali C, et al.Clinicopathological features of pancreatic endocrine tumors: a prospective multicenter study in Italy of 297 sporadic cases. The American journal of Gastroenterology . 2010
  • 10Casadei R,Ricci C,Pezzilli R,Campana D,Tomassetti P,Calculli L, et al.Are there prognostic factors related to recurrence in pancreatic endocrine tumors?. Pancreatology . 2010

二级参考文献13

  • 1Quyen D. Chu,Mazin F. Al-kasspooles,Judy L. Smith,Hector R. Nava,Harold O. Douglass,Deborah Driscoll,John F. Gibbs.Is glucagonoma of the pancreas a curable disease?[J]. International Journal of Pancreatology . 2001 (3)
  • 2Per Hellman,Maria Andersson,Jonas Rastad,Claes Juhlin,Sadettin Karacagil,Barbro Eriksson,Britt Skogseid,G?ran ?kerstr?m.Surgical Strategy for Large or Malignant Endocrine Pancreatic Tumors[J]. World Journal of Surgery . 2000 (11)
  • 3Feng LS,,Ma XX,Tang Z,Zhao YF,Ye XX,Xu PQ.Diag- nosis and treatment of insulinoma: report of 105 cases. Hepato- biliary Pancreat Dis Int . 2002
  • 4Manes G,Pellegrini A,Riccardi F,Uonio G.Rare presenta- tion of endocrine pancreatic tumour; a case of glucagonoma without necrolytic migratory erythema?. Italian Journal of Gastroenterology and Hepatology . 1995
  • 5Becker SW,Kahn D,Rothman S.Cutaneous manifestations of internal malignant tumors. Archiv fur Dermatologie und Syphilis . 1942
  • 6Frankton S,,Bloom SR.Gastrointestinal endocrine tumors. Glucagonomas. Baillieres Clin Gastroenterol . 1996
  • 7Wermers RA,Fatourechi V,Wynne AG,Kvols LK,Lloyd RV.The glucagonoma syndrome. Clinical and pathologic fea- tures in 21 patients. Medicine . 1996
  • 8Mozell E,,Stenzel P,Woltering EA,Rosch J,O‘ Dorisio TM.Functional endocrine tumors of the pancreas. Clinical presentation, diagnosis, and treatment. Current Problems in Surgery . 1990
  • 9Boden G.Insulinoma and glucagonoma. Seminars in Oncology . 1987
  • 10Chu QD,Al-kasspooles MF,Smith JL,Nava HR,Douglass HO Jr,Driscoll D, et al.Is glucagonoma of the pancreas a cur- able disease?. International Journal of Pancreatology . 2001

共引文献5

同被引文献15

引证文献5

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部